Paper34071869
Current Evidence of the Role of the Myokine Irisin in Cancer.
Tsiani E and 4 others. Cancers (Basel), 2021. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Current Evidence of the Role of the Myokine Irisin in Cancer. Papers, record 34071869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34071869
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07048847 | The Effect of Aerobic Exercise on Selective Biomarkers of Patients With Cancer | Background |
Source ClinicalTrials.gov
References105
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26278051 | Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. | Cell Metab | 2015 | https://conductscience.org/library/papers/26278051 | PubMed |
| 2 | 31701659 | Irisin reverses intestinal epithelial barrier dysfunction during intestinal injury via binding to the integrin αVβ5 receptor. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/31701659 | PubMed |
| 3 | 28620703 | Epidemiology and biology of physical activity and cancer recurrence. | J Mol Med (Berl) | 2017 | https://conductscience.org/library/papers/28620703 | PubMed |
| 4 | 27183032 | Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. | JAMA Intern Med | 2016 | https://conductscience.org/library/papers/27183032 | PubMed |
| 5 | 33359670 | The "irisin system": From biological roles to pharmacological and nutraceutical perspectives. | Life Sci | 2021 | https://conductscience.org/library/papers/33359670 | PubMed |
| 6 | 27545213 | Irisin immunostaining characteristics of breast and ovarian cancer cells. | Cell Mol Biol (Noisy-le-grand) | 2016 | https://conductscience.org/library/papers/27545213 | PubMed |
| 7 | 25261800 | A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. | Peptides | 2014 | https://conductscience.org/library/papers/25261800 | PubMed |
| 8 | 19644473 | Targeting the phosphoinositide 3-kinase pathway in cancer. | Nat Rev Drug Discov | 2009 | https://conductscience.org/library/papers/19644473 | PubMed |
| 9 | 23861558 | Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise. | Mediators Inflamm | 2013 | https://conductscience.org/library/papers/23861558 | PubMed |
| 10 | 31130826 | Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications. | Curr Anesthesiol Rep | 2018 | https://conductscience.org/library/papers/31130826 | PubMed |
| 11 | 23050972 | Role of PGC-1α signaling in skeletal muscle health and disease. | Ann N Y Acad Sci | 2012 | https://conductscience.org/library/papers/23050972 | PubMed |
| 12 | 31065382 | Exercise-Induced Irisin, the Fat Browning Myokine, as a Potential Anticancer Agent. | J Obes | 2019 | https://conductscience.org/library/papers/31065382 | PubMed |
| 13 | 26771115 | The Emerging Hallmarks of Cancer Metabolism. | Cell Metab | 2016 | https://conductscience.org/library/papers/26771115 | PubMed |
| 14 | 33112539 | Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study. | Asian Pac J Cancer Prev | 2020 | https://conductscience.org/library/papers/33112539 | PubMed |
| 15 | 28012856 | Increased FNDC5/Irisin expression in human hepatocellular carcinoma. | Peptides | 2017 | https://conductscience.org/library/papers/28012856 | PubMed |
| 16 | 29048621 | Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway. | Oncol Rep | 2017 | https://conductscience.org/library/papers/29048621 | PubMed |
| 17 | 22237023 | A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. | Nature | 2012 | https://conductscience.org/library/papers/22237023 | PubMed |
| 18 | 33134306 | Physical Activity and Breast Cancer Prevention: Possible Role of Immune Mediators. | Front Nutr | 2020 | https://conductscience.org/library/papers/33134306 | PubMed |
| 19 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 20 | 16724053 | Ras, PI(3)K and mTOR signalling controls tumour cell growth. | Nature | 2006 | https://conductscience.org/library/papers/16724053 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942453 | Association of Baseline Serum DKK-1 Levels with Subsequent Bone Metastasis in Stage III Breast Cancer. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42942453 | PubMed |
| 42512404 | Muscle-Tumor Crosstalk in Exercise Oncology: Exercise-Induced Myokines and Cancer Cachexia. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512404 | PubMed |
| 42396351 | Irisin Potentiates 5-fluorouracil Cytotoxicity in HT-29 Colon Cancer Cells through Enhanced Apoptosis and Transcriptional Modulation of Adenosine Monophosphate-activated Protein Kinase/Mammalian Target of Rapamycin Signaling. | Int J Appl Basic Med Res | 2026 | https://conductscience.org/library/papers/42396351 | PubMed |
| 42294001 | Exercise-secreted antitumor myokines: mechanistic insights and translational potential. | Front Sports Act Living | 2026 | https://conductscience.org/library/papers/42294001 | PubMed |
| 42049429 | The Role of Irisin and Physical Activity in Breast Cancer. | In Vivo | 2026 | https://conductscience.org/library/papers/42049429 | PubMed |
| 41983081 | The role of exercise-induced myokines in cancer-associated inflammation and immune regulation: mechanisms and prospects. | Front Sports Act Living | 2026 | https://conductscience.org/library/papers/41983081 | PubMed |
| 41566205 | Effects of irisin on inflammatory and apoptotic markers in the Caco-2 colon cancer cell line. | BMC Mol Cell Biol | 2026 | https://conductscience.org/library/papers/41566205 | PubMed |
| 41108364 | Running session-conditioned human serum lowers prostate cancer cell spheroid formation. | J Cancer Res Clin Oncol | 2025 | https://conductscience.org/library/papers/41108364 | PubMed |
| 40859977 | Irisin's Dual Role in Malignant Tumors and Its Potential as a Biomarker and Therapeutic Target. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40859977 | PubMed |
| 40751845 | The effect of supervised aerobic exercise on adipokine and myokine biomarkers in patients with cancer during systemic chemotherapy: a single-blinded prospective controlled trial. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/40751845 | PubMed |
| 40725790 | Irisin Concentrations in Children and Adolescent Cancer Survivors and Their Relation to Metabolic, Bone, and Reproductive Profile: A Pilot Case-Control Study. | J Clin Med | 2025 | https://conductscience.org/library/papers/40725790 | PubMed |
| 40370453 | Role and mechanisms of exercise therapy in enhancing drug treatment for glioma: a review. | Front Immunol | 2025 | https://conductscience.org/library/papers/40370453 | PubMed |
| 39859367 | Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39859367 | PubMed |
| 39582829 | Evaluate the Serum of Irisin, Omentin-1, and Oxidative Status in Males with Prostatic Cancer. | Rep Biochem Mol Biol | 2024 | https://conductscience.org/library/papers/39582829 | PubMed |
| 38604409 | Exercise training mode effects on myokine expression in healthy adults: A systematic review with meta-analysis. | J Sport Health Sci | 2024 | https://conductscience.org/library/papers/38604409 | PubMed |
| 38512830 | Trolox and recombinant Irisin as a potential strategy to prevent neuronal damage induced by random positioning machine exposure in differentiated HT22 cells. | PLoS One | 2024 | https://conductscience.org/library/papers/38512830 | PubMed |
| 37008023 | Recombinant irisin prevents cell death and mineralization defects induced by random positioning machine exposure in primary cultures of human osteoblasts: A promising strategy for the osteoporosis treatment. | Front Physiol | 2023 | https://conductscience.org/library/papers/37008023 | PubMed |
| 36733390 | Identification and validation of a muscle failure index to predict prognosis and immunotherapy in lung adenocarcinoma through integrated analysis of bulk and single-cell RNA sequencing data. | Front Immunol | 2022 | https://conductscience.org/library/papers/36733390 | PubMed |
| 36225200 | Role of irisin in physiology and pathology. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36225200 | PubMed |
| 36077366 | Implication of Irisin in Different Types of Cancer: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077366 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34071869
GET https://conductscience.org/api/papers/v1/34071869/references?page=2